70 likes | 75 Views
CapitalStars Award Winning,SEBI registered investment advisory company.We provide intraday & positional services in equity,derivative ,commodity & currency.<br>http://www.capitalstars.com/<br><br><br>
E N D
CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 22ND NOVEMBER 2018 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report INDIANFACE INDIAN MARKET CLOSE PREVIOUS ! 35199.80 INDIANEQUITYBENCHMARK:- At the close of market hours, the Sensex was down 274.71 points or 0.77% at 10600.05 35199.80, while the Nifty ended down 56.20 points or 0.53% at ASIAN MARKET 10600.00. The market breadth was negative as 1,256 shares CLOSE PREVIOUS advanced, against a decline of 1,305 shares, while 136 shares NIKKEI 21507.54 were unchanged.Yes Bank, Axis Bank, and Dr Reddy’s were the 25971.47 big gainers, while TCS and Infosys lost the most. GLOBALFACE 2082.58 SECTORIAL INDICES ! CLOSE CHANGE (%) AsianMarket- Asianmarketsfinishedmixedasofthemost recentclosingprices.TheHangSenggained0.51%andthe ShanghaiCompositerose0.21%.TheNikkei225lost0.35%. 10836.30 -0.36 -0.22 ! U.S.Market– Dowissettoreboundattheopenafteraglobal equityrout. 1.02 ! -0.25 Europeanmarkets- European markets are higher today with shares .BANK NIFTY 26262.05 0.57 in Germany leading the region. The DAX is up 0.46% while London's FTSE 100 is up 0.45% and France's CAC 40 is up 0.15%. CLOSE CHANGE (%) 2600.45 6.44 867 3.47 3.28 5868.00 3.15 TOP LOSERS CLOSE CHANGE (%) -3.47 -3.41 POWERGRID 182 -3.40 -2.54 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report NIFTYSPOT MARKET MOVERS UPSIDE STRATEGY SCRIPT CLOSE (%) 5.90 DRREDDY 2594.75 PIVOT POINTS P 10611 4.96 R1 R2 10720 RESISTANCE R1-10720 R2-10830 R3 10829 10393 10502 10551 10660 4.94 EXIDEIND SUPPORT S1-10550 S2-10390 4.29 CLOSE (%) -3.51 1811.75 TCS -3.14 INFY -2.77 POWERGRID HCLTECH -2.63 NET (CR.) BULLISH 3278.92 PIVOT POINTS P 26266 S3 S1 26123 R1 26482 R2 R3 DII 2790.96 25548 25907 RESISTANCE NSE TOTALS ADVANCE BANK NIFTY BANK NIFTY 9 3 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARSFINANCIALRESEARCHPVT.LTD. Daily Equity Report MARKET TALKS ! LupinlaunchesgenericTetrabenazine! MindaCorporationtoreducestakein MindaFurukawafrom51%to25% Auto ancillary maker, Minda Corporation Limited (MCorp)announcedthatitwillreducestakeinitsjoint venture (JV) with Furukawa (Furukawa). The JV, called Minda Furukawa Electric Private Limited (MFEPL) is currently owned 51% by MCorpand 49% byFurukawa. Post therestructuring exercise,MCorpwillreduceitsstakefrom51%to25%, whileFurukawawillraisestakefrom49%to75%.The changeinequitystructurewilltakeplacethroughamix of sale of shares of MFEPL by MCorp and additional equityinfusionintoMFEPLbyFurukawa. tablets Pharma TetrabenazineTablets,12.5mgand25mghavingreceived anapprovalfromtheUSFDAearlier.Lupin’sTetrabenazine Tablets,12.5mgand25mgarethegenericequivalentof Valeant Pharmaceuticals North America, LLC’s Xenazine tablets.Thedrugisindicatedforthetreatmentofchorea associatedwithHuntington’sdisease.Xenazinetabletshad annualsalesof$153mnintheUS(IQVIAMATSeptember 2018). major Lupin announced the launch of Group of Japan ! AdaniGasbags13citygasdistribution projects AdaniGasLtd,thecitygasdistributionarmoftheAdani Group,has baggedauthorizationfromthePetroleum and NaturalGasRegulatoryBoard(PNGRB)toexpanditscity gas footprint in 13 new Geographical Areas (GAs) in the recentlyconcluded9thround ofCGDbidding.Inaddition, the company has also won 9 GAs in its joint venture companywithIndianOilCorporation,i.e.IndianOil- Adani GasLtd.(IOAGPL),asperbsepressrelease. ! Dr.Reddy’store-launchSuboxoneinUS: TheUnitedStatesCourtofAppealsissuedadecisioninfavorofDr. Reddy'sLaboratoriesinthecasevs.Indivior.Thisdecisionwill nowallowDr.Reddy'stosellitsgenericversionofSuboxone® (buprenorphineandnaloxone)sublingualfilm.Asaresultofthis ruling,Dr.Reddy'swillresumeitslaunchactivitiesassoonas permitted.Acompanyspokespersonstated,"Wearepleasedwith thedecisionoftheappellatecourtinDr.Reddy'sfavor,vacating thepreliminaryinjunctionthathadpreventedDr.Reddy'sfrom bringingthisimportantdrugtothepublic.". Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARSFINANCIALRESEARCHPVT.LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.
CAPITALSTARSFINANCIALRESEARCHPVT.LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647
CAPITALSTARSFINANCIALRESEARCHPVT.LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.